TScan Therapeutics - Stock Price History | TCRX

Historical daily share price chart and data for TScan Therapeutics since 2021 adjusted for splits. The latest closing stock price for TScan Therapeutics as of October 15, 2021 is 6.75.
  • The all-time high TScan Therapeutics stock closing price was 13.48 on August 18, 2021.
  • The TScan Therapeutics 52-week high stock price is 14.71, which is 117.9% above the current share price.
  • The TScan Therapeutics 52-week low stock price is 6.06, which is 10.2% below the current share price.
  • The average TScan Therapeutics stock price for the last 52 weeks is 8.99.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
TScan Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.165B $0.001B
TScan Therapeutics Inc. is a biopharmaceutical company. It focused on the development of T-cell receptor engineered T cell therapies for the treatment of patients with cancer. The company's lead product pipeline consist TSC-100 and TSC-101. TScan Therapeutics Inc. is based in WALTHAM, Mass.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.216B 8.54
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.812B 20.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.815B 0.00
Emergent Biosolutions (EBS) United States $2.763B 6.66
Arcus Biosciences (RCUS) United States $2.321B 0.00
Myovant Sciences (MYOV) United Kingdom $1.993B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.769B 0.00
Zymeworks (ZYME) Canada $1.152B 0.00
Ambrx Biopharma (AMAM) United States $0.431B 0.00
SQZ Biotechnologies (SQZ) United States $0.346B 0.00
Enzo Biochem (ENZ) United States $0.188B 18.43